Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

For more on the business and cultural impact of new weight loss drugs, see our special series The Obesity Revolution.

A woman died of total organ failure after she developed complications while taking Ozempic for weight loss and metformin to control her diabetes, an inquest ...

The television was on, in the background, the other night. A programme about whales was being shown. I happened to glance up from my book at one stage and saw a dead whale being spilt open. His vast ...